Redhill Biopharma Ltd (NASDAQ:RDHL)

0.3939
Delayed Data
As of 3:57pm ET
 +0.0099 / +2.58%
Today’s Change
0.35
Today|||52-Week Range
38.40
-92.98%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +10,054.86% increase from the last price of 0.39.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
$23.5M
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
Growthannually -2,566.67%
 
 
 
 
 
 

Sales

Growthquarterly 552.32%
 
 
 
 
 
 
Growthannually -85.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.